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Abstract
Oxytocin neurons represent one of the major subsets of neurons in the paraventricular hypothalamus (PVH), a critical brain
region for energy homeostasis. Despite substantial evidence supporting a role of oxytocin in body weight regulation, it
remains controversial whether oxytocin neurons directly regulate body weight homeostasis, feeding or energy expenditure.
Pharmacologic doses of oxytocin suppress feeding through a proposed melanocortin responsive projection from the PVH to
the hindbrain. In contrast, deficiency in oxytocin or its receptor leads to reduced energy expenditure without feeding
abnormalities. To test the physiological function of oxytocin neurons, we specifically ablated oxytocin neurons in adult mice.
Our results show that oxytocin neuron ablation in adult animals has no effect on body weight, food intake or energy
expenditure on a regular diet. Interestingly, male mice lacking oxytocin neurons are more sensitive to high fat diet-induced
obesity due solely to reduced energy expenditure. In addition, despite a normal food intake, these mice exhibit a blunted
food intake response to leptin administration. Thus, our study suggests that oxytocin neurons are required to resist the
obesity associated with a high fat diet; but their role in feeding is permissive and can be compensated for by redundant
pathways.
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Introduction
The paraventricular hypothalamus (PVH) is a critical brain
region for both feeding and energy expenditure regulation [1–2].
Within the PVH, there are distinct subsets of peptidergic neurons
including oxytocin, vasopressin (AVP), thyrotropin releasing
hormone (TRH) and corticotropin releasing hormone (CRH)
neurons, which send projections throughout the brain as well as to
the median eminence (TRH and CRH) or posterior pituitary
(oxytocin and vasopressin, also including projections from the
supraoptic nucleus) [3]. These projections form the structural basis
through which the PVH in the regulates a diverse set of
physiologic functions including energy homeostasis.
Substantial data supports a role for oxytocin in regulating body
weight. Oxytocin neurons show relatively high co-localization with
the expression of FTO gene, a gene in which mutations have been
shown to be significantly associated with human obesity [4].
Reduced oxytocin neuron number and cell volume, and reduced
baseline oxytocin profiles have been associated with the Prader-
Willi syndrome, a human obesity syndrome notable for severe
hyperphagia [5–6]. Oxytocin neurons appear to at least partially
mediate the anorexigenic action of leucine [7]. Administration of
oxytocin decreases food intake while administration of oxytocin
receptor antagonists results in hyperphagia [8]. Current evidence
supports a model in which PVH oxytocin neurons project to the
nucleus of solitary tract (NTS) and release oxytocin to modulate
the activity of local hindbrain neurons and ‘‘fine tune’’ the
response of NTS neurons to satiety signals arising in the gut and/
or periphery [9–12]. In addition, diminished oxytocin has been
shown to be associated with hyperphagic obesity secondary to
haploinsufficiency of Single-minded 1, a transcription factor required
for PVH development [13]. Importantly, oxytocin reduces high-fat
induced obesity by restricting energy intake [14–15]. Consistent
with this result, a recent study suggested that synaptotagmin-4
regulates oxytocin release to modulate feeding and that defects in
this regulation may mediate diet-induced obesity [8,16]. Taken
together, these data demonstrate an important role for oxytocin in
the regulation of food intake.
Despite the compelling evidence for a role of oxytocin in feeding
regulation, there are inconsistencies regarding the role of oxytocin
in other animal studies. Mice with deficiency of oxytocin or its
receptor show either normal body weight or mild obesity [3,17–
20]. Even in the case of obesity, mice show reduced energy
expenditure but normal feeding [17,20–21]. Whether these
discrepancies could be attributable to developmental compensa-
tion in response to germline gene deletion is not clear. Previous
studies targeting agouti-related peptide (AgRP) neurons revealed
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profound developmental compensation that almost completely
masked the physiologic function of these neurons [22]. To test the
necessity of oxytocin neurons in feeding regulation and avoid any
developmental compensation occurring from germline deletion of
oxytocin or its receptor, we generated mice with a specific lesion of
oxytocin neurons in adult mice using a temporally controlled,
genetic lesioning approach. After achieving , 95% ablation of
oxytocin neurons, our results demonstrate that oxytocin neurons
are dispensable for feeding regulation in males and females, but
are required for diet induced energy expenditure and for
pharmacologic leptin action on feeding in males.
Materials and Methods
Experimental Animals
Oxytocin-Ires Cre mice were generated using recombineering
techniques as previously described [23–24]. Briefly, a selection
cassette containing and internal ribosomal entry sequence linked
to Cre recombinase and an Frt-flanked kanamycin resistance gene
was targeted just downstream of the stop codon of the Oxytocin
gene in a bacterial artificial chromosome (RP24-388N9; Chil-
dren’s Hospital Oakland Research Institute). A targeting plasmid
containing the Cre-containing selection cassette and 4 kb genomic
sequence upstream and downstream of the Oxytocin stop codon
was isolated and used for embryonic stem cell targeting. Correctly
targeted clones were identified by long range PCR and southern
blot analysis and injected into blastocysts. Chimeric animals
generated from blastocyst implantation were then bred for
germline transmission of the altered Oxytocin-allele. Flp-deleter
mice were then used to remove the neomycin selection cassette.
Mice carrying Cre-dependent expression of diphtheria toxin
receptor (DTR) were purchased from the Jackson Laboratory
(Gt(ROSA)26Sor
tm1(HBEGF)Awai/J, item number: 7900, named
Rosa26
iDTR/iDTR. Study subjects were generated by mating
Rosa26
iDTR/iDTR mice with Oxytocin-Ires-Cre mice, from Oxytocin-
Ires-Cre:Rosa26
iDTR/+ mice and their littermate control group
Rosa26
iDTR/+ mice were generated. Since study subjects are
littermates, potential genetic variation is equally distributed to
study groups. To visualize Oxytocin-Ires-Cre expression, Oxytocin-Ires-
Cre mice and Oxytocin-Ires-Cre:Rosa26
iDTR/+ mice were crossed with
B6.Cg-Gt(ROSA)26Sor
tm9(CAG-tdTomato)Hze/J mice (Ai9 mice,
Jackson Laboratory, Bar Harbor, ME) to generate Oxytocin-Ires-
Cre:Ai9 mice and Oxytocin-Ires-Cre:Rosa26
iDTR/+Ai9 mice in which
Cre expression can be directly visualized by tdTomato, a variant
red fluorescence protein (RFP), using fluorescent microscopy [25].
Mice were housed at 22uC–24uC with a 12 hr light/12 hr dark
cycle with food and water provided ad libitum. To achieve specific
oxytocin neuron ablation, we used a strategy similar to that used
previously for hypothalamic neuron ablation. Briefly, Oxytocin-Ires-
Cre:Rosa26
iDTR/+ mice around 9 weeks of age were injected
intraperitoneally with diphtheria toxin (DTX; 40 ng/g body-
weight); a second dose was administered one week later. Control
Rosa26
iDTR/+ mice also received the same DTX treatment. All
animals and procedures were approved by the animal welfare
committee of the University of Texas Health Science Center at
Houston.
Body Weight Studies
Weekly body weight was monitored in Rosa26
iDTR/+ mice (or
control mice after DTX treatment) and Oxytocin-Ires-Cre:Ro-
sa26
iDTR/+ mice (or lesion mice after DTX treatment) fed standard
mouse chow (Teklad F6 Rodent Diet 8664, Harlan Teklad,
Madison, WI) from 4 to 20 weeks of age. For the high-fat diet
study, a separate cohort of control and lesion mice were switched
from chow diet to high fat, high sucrose diet (HFD, D12331 from
Research Diets, NJ) from 10 weeks of age and maintained on HFD
for 12 weeks. Body weight was monitored weekly. Body
composition was measured at the end of study (22 weeks of age)
using an Echo-MRI machine.
Energy Expenditure and Food Intake Measurements
Energy expenditure was assessed by measuring oxygen
consumption with indirect calorimetry. Individually housed
control and lesion mice maintained on chow diet at 12 weeks of
age were placed at room temperature (22uC–24uC) in chambers of
a Comprehensive Lab Animal Monitoring System (CLAMS,
Columbus Instruments, Columbus, OH). Food and water were
provided ad libitum. Mice were acclimated in the chambers for
48 hr prior to data collection. Oxygen consumption was first
measured using mice fed chow for 2 days followed by another 2
days on HFD. Average O2 consumption was calculated for chow
diet and HFD, and compared between genotypes. Daily food
intake was measured for 1 week using mice that were individually
housed for at least 1 week prior to assessment. Daily food intake
was calculated from averaged food intake across the week.
Immunohistochemistry (IHC) Assays
For IHC experiments, free-floating brain sections were rinsed
with PBS (pH 7.4) containing 0.1% Triton X-100 for 30 minutes,
followed by the blocking in PBS containing 5% normal goat serum
(Thermo scientific, Rockford, IL) and 0.3% Triton X-100 for 1
hour at room temperature. The sections were then incubated with
polyclonal rabbit anti-OXYTOCIN (1:1000, Phoenix), or poly-
clonal anti-AVP (rabbit 1:500, Sigma or guinea pig 1:1000,
Phoenix) in PBS containing 2% normal goat serum and 0.2%
Triton X-100 overnight at 4uC, respectively. For IHC on pituitary,
pituitary tissues were taken out and post-fixed in 4% formalin
overnight. Pituitary sections at 10 mM thickness were cut using
a crytostat (Leica, Germany) and IHC was performed as described
above on floating sections using the anti-AVP antibody. All
sections were visualized and photographed with a TCS SP5
confocal microscope (Leica, Germany). To quantify cell numbers,
in each mouse (n=324), three sections at corresponding
rostrocaudal levels (Bregma levels 20.58, 20.82 and
20.94 mm) were chosen. All immune-positive cells with clear
profile were counted and the numbers from all animals were
summed and then averaged as the number per section.
Leptin and MTII Effects On Food Intake
For leptin feeding experiments, a protocol similar to that
previously described was used [26]. Individually housed male mice
(11 wks) were acclimatized to daily injections of 200 ml of saline
solution for 5 consecutive days before drug treatment. The day
before experiment, mice were fasted overnight. After that, each
mouse received either a saline or an intraperitoneal (i.p.) injection
of recombinant murine leptin (Dr. F. Parlow, NHPP, 4.0 mg/g).
Cumulative food intake and body weight was measured 2, 4 and
24 h after injection. After one week of recovery, the same protocol
was performed in a cross-over fashion: the mice previously treated
with saline received leptin and vice versa. The effect of leptin on
food intake was calculated by normalizing food intake after leptin
treatment to that observed after saline for each individual animal;
this ratio was then averaged within each genotype.
MTII was purchased from Bachem (Torrance, CA). Male
control and lesion mice on a chow diet, aged 12 wks, were housed
individually for 5 days. Three days before the experiment the mice
were habituated to daily i.p. injections using sterile saline. The
Oxytocin Neurons in Energy Balance
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On the day of the experiment, food was removed 4 h before the
onset of the dark cycle (1400 h). At the onset of the dark cycle
(1800 h), mice were injected i.p. with saline or 5 mg/kg MTII in
saline. Cumulative food intake and body weight was measured 2,
4, and 24 h after injection.
Quantitative PCR Assay
RNA was extracted from hypothalamic micro-punches using
the Trizol Reagent (Invitrogen), reverse transcribed with RETRO-
script (Ambion) and amplified using SYBR green technology (Bio-
Rad, Hercules, CA). The primers for oxytocin are 59-CAA-
GAGGGCTGTGCTGGACCTGGATAT-39 and 59-
GCGGGGTCTGTGCGGCAGCCA-3, for AVP are 59-
CTCCGCTTGTTTCCTGAGCCTGCTG -39 and 59-AG-
CAGCGTCCTTTGCCGCCCGG-39, for TRH are 59-
GATGGCTCTGGCTTTGATCTT-39 and 59- GATCTAT-
GAACCTCCGGCCT-39, and for CRH are 59-
CATGCGGCTGCGGCTGCTGGTGT-39 and 59-
GCGGCGCTCGGGGGACGGAT-39. Assays were linear over
five orders of magnitude.
Statistical Analyses
Data sets are presented as mean 6 SEM and analyzed for
statistical significance using PRISM (GraphPad, San Diego, CA)
for appropriate Student’s t tests. A P value of ,0.05 was required
for significance.
Results
To achieve specific targeting of oxytocin neurons using Cre-
loxP technology, we generated mice with Cre expression selective
to oxytocin neurons. To ensure that Cre expression matches that
of oxytocin, we employed a knock-in strategy and placed a DNA
cassette containing an internal ribosomal sequence (IRES), Cre
coding sequence and polyadenylation sequence directly after the
stop codon of the endogenous oxytocin gene using homologous
recombination (Fig. 1A). In this configuration, Cre and oxytocin
are transcribed as a single mRNA and the IRES sequence allows
simultaneous translation of both oxytocin and Cre proteins from
the same mRNA, thus ensuring the co-expression of oxytocin and
Cre. To confirm appropriate co-expression, we crossed mice
harboring Oxytoin-Ires-Cre with a Td-tomato reporter strain which
expresses Td-Tomato in a Cre-dependent manner. Using brain
sections from the double transgenic mice (Oxytocin-Ires-Cre:Td-
tomato), we performed immunostaining for oxytocin. We found
a near complete colocalization of dsRed(red) and oxytocin (green)
only in the PVH and the supraoptic nuclear, where oxytocin is
known to be expressed (Fig. 1B). Approximately 92% of cells
containing oxytocin immunoreactivity also expressed Cre activity
in the PVH (n=2). Similar patterns of colocalization were also
seen using other Cre-dependent fluorescent reporter strains (data
Figure 1. Oxytoin-Ires-Cre knock-in mice express Cre recombinase in oxytocin neurons. A) Cre recombinase was targeted just after the stop
codon of the Oxytocin gene using an internal ribosomal entry site (ires). B) Immunohistochemistry for Oxytocin on brain slices of Oxytocin-Ires-Cre:Td-
tomato reporter (Ai9) mice indicates that nearly all oxytocin-containing neurons (green) express Cre recombinase. C) Oxytocin-ires Cre activity (red)
does not colocalize significantly with AVP immunoreactivity (green) in the PVH. Images were taken at 20X magnification.
doi:10.1371/journal.pone.0045167.g001
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PLOS ONE | www.plosone.org 3 September 2012 | Volume 7 | Issue 9 | e45167Figure 2. Specific lesion of oxytocin neurons. A and A9: Cre-dependent reporter RFP expression in Oxytocin-Ires-Cre:Ai9 mice (control, A) and
Oxytocin-Ires-Cre:Rosa26
iDTR/+:Ai9 mice (lesion, A9) after DTX administration. While numerous RFP positive neurons in control mice, reminiscent of
oxytocin neurons, only a few positive neurons in lesion neurons (Arrows in A9). B and B9: Immunostaining for oxytocin in Oxytocin-Ires-Cre:Ai9 mice
(control, B) and Oxytocin-Ires-Cre:Rosa26
iDTR/+:Ai9 mice (lesion, B9) after DTX administration. While numerous oxytocin positive neurons in control mice,
negligible number of oxytocin positive neurons in lesion neurons (Arrows in B9). C and C9: Immunostaining for AVP in Oxytocin-Ires-Cre:Ai9 mice
Oxytocin Neurons in Energy Balance
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expression appear not to express oxytocin in the overlay (Fig. 1B,
arrows). This may reflect the fact that oxytocin expression in these
neurons is too low for detection by immunostaining as it has been
shown before that the number of oxytocin-expressing neurons
depends on physiologic status [3]. In addition, almost all
neighboring AVP neurons in the PVH are devoid of Cre activity
in the Oxytocin-ires Cre mice (Fig. 1C), further suggesting that
nearly all Cre activity is limited to oxytocin neurons. Thus, we
have successfully generated Oxytocin-Ires-Cre mice, in which Cre
expression nearly completely matches that of oxytocin. This strain
can therefore be used for specifically targeting oxytocin neurons.
To achieve specific lesion of oxytocin, we crossed Oxytocin-Ires-
Cre mice with Rosa26
iDTR/+ mice to generate Oxytocin-Ires-
Cre:Rosa26
iDTR/+ mice. Rosa26
iDTR/+ mice express DTR, which is
absent in mice, in a Cre-dependent manner. Upon administration
of diptheria toxin (DTX), cells with DTRs take up DTX, which
then causes cell death [27]. This approach has been successfully
used for the lesion of neurons and other cell types [22,28–29]. To
efficiently detect the Cre-expressing neurons, we further crossed
Oxytocin-Ires-Cre:Rosa26
iDTR/+ mice with a Cre-reporter line, Ai9
mice, which express ds-red with strong red fluorescence in a Cre-
dependent manner [25]. To lesion oxytocin neurons in adulthood,
we injected DTX (40 ng/g) by i.p. to Oxytocin-Ires-Cre:Rosa26
iDTR/+
mice (lesion) and Rosa26
iDTR/+ mice mice (control). Two weeks
after injection, while we saw numerous neurons with dsRed-signal,
representing Cre-expressing oxytocin neurons in control mice
(Fig. 2A), we were only able to observe a few neurons in lesion
mice (Fig. 2A9), suggesting efficient ablation of Cre-expressing
neurons. To directly confirm the killing of oxytocin neurons, we
performed immunostaining for oxytocin. As expected, we saw
numerous oxytocin neurons in the PVH (Fig. 2B) and the
supraoptic nucleus (not shown) of control mice. However, only
a few oxytocin neurons can be observed in the PVH (Fig. 2B9) and
the SON (not shown) of lesion mice (Fig. 2B9). To assess the degree
of oxytocin lesion, we counted the number of oxytocin positive
neurons. Whereas there were around 70+/25 oxytocin positive
neurons in a control PVH field, only 3+/21oxytocin positive
neurons were observed in a similar area in lesion mice (Fig. 2E,
n=3 mice). To determine whether the lesion is specific to oxytocin
neurons, we performed immunostaining for vasopressin (AVP),
which is expressed in a subset of neurons located in close proximity
to oxytocin neurons. We observed a similar expression pattern of
vasopressin neurons in control (Fig. 2C) and lesion mice (Fig. 2C9).
When counted, the numbers of vasopressin neurons are similar
between the treatments (Fig. 2F). Consistent with dramatic
reduction in number of oxytocin neurons, oxytocin positive fibers
in the posterior pituitary, the major projection site of oxytocin
neurons was also dramatically reduced in lesioned mice (Fig. 2D9),
compared to control mice (Fig. 2D). To further verify lesion of
oxytocin neurons, we examined oxytocin expression in the
hypothalamus and oxytocin levels in the blood. Using hypotha-
lamic tissues obtained from mice 2 weeks after last DTX injection,
oxytocin mRNA was severely reduced in lesioned mice compared
to control mice (Fig. 3A). In agreement with our cell counts, AVP
mRNA expression in the hypothalamus was not different between
control and lesioned mice (Fig. 3B). Furthermore, mRNA levels in
the hypothalamus were comparable between control and lesioned
(control, C) and Oxytocin-Ires-Cre:Rosa26
iDTR/+:Ai9 mice (lesion, C9) after DTX administration. Similar patterns of AVP immunostaining were observed in
both genotypes. D and D9: Immunostaining for oxytocin in the posterior pituitary of Oxytocin-Ires-Cre:Ai9 mice (control, D) and Oxytocin-Ires-
Cre:Rosa26
iDTR/+:Ai9 mice (lesion, D9) after DTX administration. While intensive oxytocin positive projections were observed in control mice (arrow in
D), weak immunostaining was observed in lesion mice (Arrows in D9). We counted oxytocin and AVP positive neurons from matched PVH sections
from each genotype (n=3 each). The number of oytocin neuron was dramatically reduced (E) while AVP neuron number remained comparable (F).
***: p,0.001 using two tailed Student’s T test. Scale bars, 100 mm.
doi:10.1371/journal.pone.0045167.g002
Figure 3. Expression of transcripts of PVH neuropeptides. Hypothalamic tissues were punched out from 10 weeks old mice of Oxytocin-Ires-
Cre:Rosa26
iDTR/+ mice (lesion, n=6) and Oxytocin-Ires-Cre mice (control, n=7) that received DTX injections two weeks before. Expression of mRNA
assessed by Q-PCR assays with GAPDH as an internal control using the punched tissues were shown for oxytocin (A), AVP (B), CRH (C) and TRH (D).
**P,0.01 using two tailed Student’s T test.
doi:10.1371/journal.pone.0045167.g003
Oxytocin Neurons in Energy Balance
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thyrotropin releasing hormone (Fig. 3D). Thus, we have achieved
efficient and specific lesion of oxytocin neurons in adult mice.
Cre expression alone can sometimes cause a difference in
baseline body weight. To control for the potential effect of
Oxytocin-Ires-Cre expression on body weight, we monitored body
weight of Oxytocin-Ires-Cre:Rosa26
iDTR/+ mice and its control
Rosa26
iDTR/+ mice up to 8 weeks of age. There was no difference
in body weight between genotypes in males or females on chow
(data not shown). In addition, to ensure a stable body weight with
drug treatments, we administered saline once a week at the ages of
8 and 9 weeks before DTX administration. We found that the
body weights of both groups remained stable and comparable
during 2 weeks of measurement in males and females (Fig. 4 A–C).
These data demonstrate that Oxytocin-Ires-Cre:Rosa26
iDTR/+and
Rosa26
iDTR/+ mice have the same baseline body weight. At 9
weeks of age, we administered DTX as described in Fig. 2.
Following DTX administration, we monitored weekly body
weights of control and lesion groups fed chow diet. Compared
to the control group, lesioned male (Fig. 4A) and female (data not
shown) mice exhibited similar body weight through 20 weeks of
age, suggesting that oxytocin neurons are dispensable for body
weight regulation on standard chow diet.
Mice lacking oxytocin or oxytocin receptor display late onset
obesity with normal food intake [17,20]. This suggests a defect in
energy expenditure. To assess this possibility, we used high fat diet
as a physiologic challenge for mice lacking oxytocin neurons. The
animals were treated as described for the chow diet, but switched
to high fat diet upon completion of DTX administration. Weekly
body weights of lesion and control groups were measured through
22 weeks of age. In males, compared to the control group, lesion
mice exhibited a comparable body weight up to 14 weeks of age,
and then slowly developed higher body weight (Fig. 4B). At 22
weeks of age, lesion mice had body weight of (36.1+/21.3 grams)
while control group had body weight of (32.0+/21.1 grams). In
contrast, in females, lesioned mice exhibited no difference in body
weight on HFD up to 22 weeks of age (Fig. 4C). These data suggest
that oxytocin neurons are required for normal body weight
regulation in response to HFD feeding in males, yet are
dispensable in females. Since only lesioned males showed a body
weight phenotype on HFD, we focused primarily on males in the
following experiments.
To characterize the higher body weight in lesioned mice, we
measured the body composition of lesioned and control mice fed
HFD at 22 weeks of age (Fig. 4B). While lean masses of the
different genotypes are comparable, fat mass is significantly higher
in lesioned mice than in controls (Fig. 4D). To examine whether
oxytocin neuron lesion affects feeding, we measured food intake of
control and lesion mice on both chow and HFD. Average daily
food intake over a one week period was comparable between
genotypes on both chow and HFD (Fig. 5A), suggesting that
oxytocin neurons are dispensable for food intake regulation on
both chow and HFD. Given the difference in body weight between
high fat diet treated groups but no difference in food intake, we
next examined whether oxytocin neuron lesion alters energy
expenditure in response to high fat diet challenge. We subjected
mice to O2 consumption measurement using metabolic chambers
(comprehensive lab animal monitoring system, CLAMS, Colum-
bus, Ohio). We used cohorts of weight-matched mice at 14–15
weeks of age treated with DTX at 9 and 10 weeks of age, and there
was no difference in body weight between genotypes. The animals
were first measured for O2 consumption on chow for 2 days
Figure 4. Body weight homeostasis in control and lesion mice. For body weight studies, Oxytocin-Ires-Cre:Rosa26
iDTR/+:Ai9 mice (lesion) and
Oxytocin-Ires-Cre:Ai9 mice (control) were first received two doses of saline treatment, each at 8 and 9 weeks of age, and then 2 doses of DTX, each at
10 and 11 weeks of age. Weekly body weight of these mice was measured up to 22 weeks of age on males fed chow (A, n=7–8), males fed HFD (B,
n=6–8) and females fed HFD (C, n=9–10). D. Body composition was determined at 22 weeks of mice shown in B. *p,0.05, two tailed Student’s T
test.
doi:10.1371/journal.pone.0045167.g004
Oxytocin Neurons in Energy Balance
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When normalized to body weight, there was no difference in O2
consumption between genotypes during the chow period; howev-
er, O2 consumption appeared to be lower in lesioned mice
compared to control mice during the HFD period, especially
during the dark cycle (Fig. 5B). To rule out the possibility that
lower O2 consumption is due to a difference in body weight or
composition [30]., we also analyzed the data based on individual
animal and saw a similarly lower O2 consumption in lesion mice
on HFD (Fig. 5C). Indeed, statistical analysis showed that O2
consumption on HFD was significantly lower in lesioned mice
compared to control mice; on a standard chow diet there was no
difference in oxygen consumption between the groups.(Fig. 5D).
Taken together, these data suggest that oxytocin neurons are
required for the stimulation of energy expenditure in response to
HFD feeding.
A previous study on lesioned AgRP neurons suggests the
possibility of functional compensation in response to acute lesion
[31]. To examine the possibility that acute lesion of oxytocin
neurons induces functional compensation in feeding circuits and
thereby masks a feeding effect in mice with oxytocin lesion, we
tested the feeding response to leptin and MTII, an agonist of the
melanocortin receptors. We used a cohort of control and lesion
mice with comparable body weights. After overnight fasting, leptin
administration significantly reduced 2- and 4-hour feeding in
control mice by 25%, and also blunted 24-hour feeding by 20%
(although this difference between treatment groups didn’t reach
the level of significance). However, in lesion mice, leptin only
produced 25% reduction of 2-hour feeding and the effects of leptin
on 4- and 24-hour feeding are not significant between treatment
groups (Fig. 6A). These results suggest that oxytocin neuron lesion
leads to a blunted response to pharmacologic leptin action on
feeding. For MTII, we examined its effect on feeding in the dark
cycle, as previously established [1]. MTII potently reduced food
intake to a similar degree in both control and lesion mice at 2- 4-
and 12-hours post injection (Fig. 6B), suggesting that oxytocin
neurons are dispensable for MTII mediated effects on feeding.
Discussion
Compelling pharmacologic evidence suggests that oxytocin is
anorexigenic, yet genetic models of oxytocin or oxytocin receptor
deficiency display normal food intake with reduced energy
expenditure [3]. To investigate this discrepancy, this study was
designed to examine the physiological function of oxytocin
neurons through specific oxytocin neuron lesion in adulthood.
This approach eliminates the possibility of developmental com-
pensation potentially associated with gene deletion during early
Figure 5. Food intake and energy expenditure in control and lesion mice. A. Daily food intake measured as average of 7-day consecutive
daily food consumption of males fed chow and HFD at 14–15 weeks of age shown in Fig. 3A and B. Oxygen consumption was measured for male
mice during 2 days on chow following by 2 days on HFD (n=627 each), and the oxygen consumption of both genotypes was analyzed based on
body weight (B) and on individual animal (C). D. O2 consumption across chow and HFD periods shown in C was averaged and compared between
genotypes. *p,0.05, two tailed Student’s T test.
doi:10.1371/journal.pone.0045167.g005
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receptor deficiency. Using Oxytocin-Ires-Cre mice generated in this
study, we have achieved specific lesion of oxytocin neurons
through a combination of Cre-mediated expression of DTR in
oxytocin neurons and adult DTX administration. This DTR-
based lesion approach has been used by others to effectively lesion
POMC and AgRP neurons [22,28]. Our lesion targeted more
than 95% of oxytocin neurons with a high degree of specificity, as
there was no reduction in nearby AVP neurons or levels of CRH
or TRH mRNA after oxytocin neuron lesioning. This suggests
that our Oxytocin-Ires-Cre mice express Cre selectively in the vast
majority, if not all, of oxytocin neurons and will be useful in future
studies targeting oxytocin neurons for genetic manipulation.
Our results showed that adult lesion of oxytocin neurons had no
effect on body weight, food intake or energy expenditure on chow.
Previous results using mice with deficiency of oxytocin or its
Figure 6. Food intake response to leptin and MTII. Control and lesion mice (n=9 each) were treated with saline and DTX as in Fig. 3. All
animals were singly housed for at least 1 week before feeding experiments. A. After overnight fasting, half of animals received saline and the other
half leptin treatment, and one week later the same feeding experiment was repeated but in a crossover fashion. Food intake with leptin treatment
was normalized and compared to that with saline treatment at 2, 4 and 24 hour periods. *p,0.05; #p=0.082; $p=0.069; ns, p.0.05 using paired
Student’s T test. B. Food intake measurement was started at the onset of the dark cycle (8 pm) after 2-hour food deprivation. The MTII administration
and data analysis was conducted in the same fashion as described in A. *p,0.05, ns, p.0.05 using paired Student’s T test.
doi:10.1371/journal.pone.0045167.g006
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chow [17,20]. The difference between these studies and ours may
be related to different genetic backgrounds between study subjects,
housing conditions or different diets used. Evidence for the
potential importance of dietary differences stems from our results
showing that mice that lack oxytocin neurons develop obesity on
HFD with normal food intake but reduced energy expenditure.
The selective effect on energy expenditure is consistent with the
metabolic effects associated with deficiency of oxytocin or its
receptor, both of which also exhibit selective reduction in energy
expenditure, but not food intake [17,20]. In addition, oxytocin
neurons are anatomically positioned to regulate energy expendi-
ture. Oxytocin neurons are located in the PVH and the PVH has
been implicated in energy expenditure regulation through
projections to the raphe pallidus or to the spinal cord, which
control sympathetic output to the brown fat tissues, the major
thermogenic organ in rodents [2,32].
Interestingly, despite the limited affect on physiological food
intake on chow or HFD, oxytocin neuron lesion led to a blunted
response to the anorexigeic effect of leptin. This result suggests that
oxytocin neurons at least partly mediate leptin action on feeding
and that functional compensation for leptin action occurs in
response to inducible loss of oxytocin neurons. It has been shown
previously that adult lesion of AgRP neurons produces a starvation
phenotype, which is averted in the setting of leptin-deficient
obesity [31]. This result suggests that rapid functional compensa-
tion from redundant pathways exist and are sufficient to
ameliorate the detrimental effects of acute neuron loss or
dysfunction. Given the biological importance of food intake
regulation, it is plausible that oxytocin neurons represent just one
subset of downstream neurons that mediate leptin action on food
intake. In the setting of oxytocin neuron loss or dysfunction one
might imagine that non-oxytocin, leptin-responsive pathways
assume the function of the ‘‘lost’’ oxytocin neurons and restrain
food intake. For example, in the absence of oxytocin, AVP can
bind and activate oxytocin receptors [33] and AVP is up-regulated
in response to salt challenging [34]. These results suggest that AVP
can be one of the candidates that compensate for oxytocin neuron
function. In support of this, the AVP pathway has previously been
shown to be involved in feeding regulation [35]. Of note, mRNAs
of AVP and other known neuropeptides in the PVH remain at
comparable levels in oxytocin neuron lesioned mice relative to
controls, suggesting that these neuropeptides cannot compensate
for oxytocin neuron ablation at the transcription level under these
experimental conditions. Nonetheless, the blunted feeding re-
sponse to leptin following oxytocin neuron ablation suggests that
redundant pathways are not sufficient to fully compensate in
response to acute pharmacologic leptin administration. In this
regard, it is important to note that the observed effects of oxytocin
on feeding are largely based on pharmacologic studies [9,13–
14,36]. On the other hand, the deficits in high fat diet induced
energy expenditure observed in this experimental paradigm
suggest a less ‘‘plastic’’ neural pathway regulating diet induced
energy expenditure that is unable to compensate for the acute loss
of oxytocin neurons. Thus, our results suggest that oxytocin
neurons are involved in both energy expenditure and food intake.
Specifically, oxytocin neuron-mediated energy expenditure is
required for response to high-fat feeding while their function in
food intake can be masked by redundant pathways under normal
conditions but may be revealed by acute pharmacologic
approaches. These results provide an explanation for the
discrepancy between results from pharmacological studies suggest-
ing a selective role of oxytocin in feeding and those from genetic
studies suggesting a selective role in energy expenditure.
Oxytocin neuron lesion had no effect on melanocortin agonist
inhibition of feeding, but produced a blunted response to leptin.
Although somewhat unexpected, this finding supports the concept
that melanocortin and leptin feeding circuits do not completely
overlap. For example, GABAergic non-POMC neurons in the Arc
may mediate leptin action on feeding through GABAergic action
onto PVH neurons including oxytocin neurons [24,37]. In
addition, a recent report suggests that a small subset of PVH
neurons express leptin receptors, which may directly engage
oxytocin neurons in mediating leptin action on feeding [38]. The
dispensable role of oxytocin neurons in MTII action on feeding is
consistent with the result that oxytocin is dispensable for feeding
inhibition by Cholecystokinin, which requires MC4R action
[18,39].
Surprisingly, our results suggest that the function of oxytocin
neurons in body weight regulation is sexually dimorphic, i.e.
oxytocin neurons are required for energy balance in males, but not
in females. A literature survey indicates that previous studies on
oxytocin in feeding and body weight were primarily focused on
males. This result is consistent with the previous result that
oxytocin receptor deletion leads to obesity only in males, but not in
females [20]. It might be the case that in females oxytocin neurons
are preferentially involved in other functions such as reproduction
and stress. For example, oxytocin has been reported to have
opposite roles in anxiety-related behaviors in males and females
[40]. One study, however, demonstrated that oxytocin deficiency
in females led to obesity in a similar fashion to males [17]. The
discrepancy cannot be explained by different diets used since our
lesion females had comparable body weights to controls on both
chow and HFD. Whether it is due to difference genetic
background or represents a variable associated with developmen-
tal compensation is unknown.
In summary, inducible lesion of oxytocin neurons in adult mice
demonstrates that oxytocin neurons are required for diet induced
energy expenditure but are not necessary for food intake
regulation. Moreover, whereas oxytocin neurons are required for
a full physiologic response to leptin administration, they are
dispensable for the anoretic action of melanocortin agonists. This
suggests that additional, non-oxytocin dependent neural circuits
play important roles in the regulation of food intake.
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